Hearing Loss, Sudden: Clinical Trials

9 trials for Hearing Loss, Sudden, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 not yet recruiting, 2 unknown, 1 suspended. 9 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 3, Not yet recruiting 3, Unknown 2, Suspended 1
Phase 23Unknown 2, Completed 1

Follow Hearing Loss, Sudden: new trials by email Literature Review of Hearing Loss, Sudden trials Research Report on Hearing Loss, Sudden

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Circulating Extracellular Vesicles for Total-Type Sudden Sensorineural Hearing Loss
autologous circulating extracellular vesicles, Glucocorticoids - Sudden Sensorineural Hearing Loss (SSNHL)
Phase 3Not yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University1462026-09-152026-10-16
Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss
Aspirin + Acid folic, Placebo Aspirin + Placebo Acid folic - Sudden Sensorineural Hearing Loss
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris1422026-04-012026-01-14
Evaluation of Oral Corticosteroid Therapy in Idiopathic Sudden Unilateral Hearing Loss.
prednisone - oral corticosteroid 1mg/kg/D for 1 week, Placebo - Sudden Sensorineural Hearing Loss
Phase 3Not yet recruitingCentre Hospitalier Universitaire de Besancon4302025-11-012025-07-24
Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
Platelet Rich Plasma, local anesthesia in external auditory canal, Intratympanic Injection - Hearing Loss, Sudden, Hearing Loss, Sensorineural
Phase 2 / Phase 3UnknownAssiut University232023-06-012023-04-19
Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss
SENS-401, Placebo Oral Tablet - Severe Sudden Sensorineural Hearing Loss
Phase 2 / Phase 3CompletedSensorion1152019-02-152023-03-01
Caroverin and Inner Ear Diseases
Caroverin - Tinnitus
Phase 3SuspendedPhafag AG1702011-01-012015-08-07
Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
bed rest, prednisone - oral corticosteroid 1mg/kg/D for 1 week - Sudden Loss of Hearing
Phase 2 / Phase 3UnknownSheba Medical Center602006-06-012006-12-27
Sudden Deafness Treatment Trial
prednisone, methylprednisolone sodium succinate - Sudden Deafness
Phase 3CompletedMassachusetts Eye and Ear Infirmary2552004-12-012017-04-04
Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss
Dexamethasone-dihydrogenphosphate (4mg/ml) - Sudden Deafness
Phase 3CompletedUniversity Hospital Tuebingen232003-10-012008-02-05

Narrower conditions

Blast Injuries (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Sensorineural (1)  ·  Presbycusis (1)  ·  Tinnitus (1)

Broader conditions

Ear Diseases (9)  ·  Hearing Disorders (9)  ·  Nervous System Diseases (9)  ·  Neurologic Manifestations (9)  ·  Otorhinolaryngologic Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Sensation Disorders (9)  ·  Signs and Symptoms (9)  ·  Hearing Loss (8)  ·  Barotrauma (1)  ·  Hearing Loss, Sensorineural (1)  ·  Wounds and Injuries (1)

Interventions

Fumigant 93 (2)  ·  Anesthesia, Local (1)  ·  Aspirin (1)  ·  Bed Rest (1)  ·  Folic Acid (1)  ·  Glucocorticoids (1)  ·  Injection, Intratympanic (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Prednisone (1)  ·  SENS-401 (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Phafag AG (1)  ·  Sensorion (1)  ·  Sheba Medical Center (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  University Hospital Tuebingen (1)

Countries

France (3)  ·  Germany (2)  ·  Israel (2)  ·  Austria (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Serbia (1)  ·  Slovakia (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Eldar Carmel, MD (1)  ·  Haidi Yang, Doctor (1)  ·  Hans-Peter Zenner, M.D. (1)  ·  Stefan K Plontke, M.D. (1)  ·  Steven Rauch, MD (1)  ·  Wolfgang Elsaesser, Dr. (1)

Results publications

PMID 19172627, PMID 21610239, PMID 22805100

NIH funding

2009 (1), U01DC006296 (1)